GlassScriptPhysician profile
Denny Nguyen
NPI 1912751249
$3,590.76
in general payments reported to CMS, 2019-2025
18 companies · $3,243 in 2025
The $3,243 reported for 2025 was more than what 97% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $347 · 2025: $3,243.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,763 · Travel and Lodging: $688 · Education: $140.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,763.48 |
| Travel and Lodging | $687.78 |
| Education | $139.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $1,602.83 | 2025 | Barostim Neo System |
| Amgen INC. | $303.51 | 2024-2025 | Repatha, Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $240.06 | 2025 | Lifevest |
| Novo Nordisk INC | $223.06 | 2025 | Wegovy, Ozempic, Rybelsus |
| Novartis Pharmaceuticals Corporation | $194.01 | 2024-2025 | |
| Abbott Laboratories | $187.42 | 2024-2025 | Aveir, Jot Dx |
| Merck Sharp & Dohme LLC | $146.32 | 2025 | Verquvo, Capvaxive |
| Medtronic, INC. | $139.50 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $129.23 | 2024-2025 | Camzyos, Eliquis |
| Pfizer INC. | $88.06 | 2024-2025 | |
| Kestra Medical Technology Services, INC. | $77.17 | 2025 | Assure Wcd |
| Astrazeneca Pharmaceuticals LP | $66.13 | 2025 | Farxiga |
| Boston Scientific Corporation | $49.36 | 2025 | Watchman Access System |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.68 | 2025 | Jardiance |
| Bridgebio Pharma, INC. | $32.11 | 2025 | Attruby |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $27.32 | 2024 | |
| Daiichi Sankyo INC. | $25.00 | 2024 | Injectafer |
| Regeneron Healthcare Solutions, INC. | $18.99 | 2024 | Evkeeza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denny Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.